Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCN) Receivables (2016 - 2025)

Chs' Receivables history spans 16 years, with the latest figure at $4.7 billion for Q4 2025.

  • For Q4 2025, Receivables rose 8.87% year-over-year to $4.7 billion; the TTM value through Nov 2025 reached $4.7 billion, up 8.87%, while the annual FY2025 figure was $4.3 billion, 6.9% up from the prior year.
  • Receivables for Q4 2025 was $4.7 billion at Chs, up from $4.3 billion in the prior quarter.
  • Across five years, Receivables topped out at $4.7 billion in Q4 2022 and bottomed at $2.5 billion in Q3 2021.
  • The 5-year median for Receivables is $3.9 billion (2022), against an average of $3.8 billion.
  • The largest annual shift saw Receivables surged 59.32% in 2021 before it decreased 28.42% in 2023.
  • A 5-year view of Receivables shows it stood at $4.2 billion in 2021, then rose by 12.7% to $4.7 billion in 2022, then decreased by 11.06% to $4.2 billion in 2023, then increased by 2.77% to $4.3 billion in 2024, then grew by 8.87% to $4.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CHSCN's Receivables are $4.7 billion (Q4 2025), $4.3 billion (Q3 2025), and $4.7 billion (Q2 2025).